HRP20220700T1 - Vezikularne formulacije za uporabu u liječenju boli ili smanjene pokretljivosti zgloba - Google Patents
Vezikularne formulacije za uporabu u liječenju boli ili smanjene pokretljivosti zgloba Download PDFInfo
- Publication number
- HRP20220700T1 HRP20220700T1 HRP20220700TT HRP20220700T HRP20220700T1 HR P20220700 T1 HRP20220700 T1 HR P20220700T1 HR P20220700T T HRP20220700T T HR P20220700TT HR P20220700 T HRP20220700 T HR P20220700T HR P20220700 T1 HRP20220700 T1 HR P20220700T1
- Authority
- HR
- Croatia
- Prior art keywords
- use according
- vesicular formulation
- vesicular
- treatment
- formulation
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
- A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
- A61K31/688—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols both hydroxy compounds having nitrogen atoms, e.g. sphingomyelins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
- A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers
- A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers comprising non-phosphatidyl surfactants as bilayer-forming substances, e.g. cationic lipids or non-phosphatidyl liposomes coated or grafted with polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Molecular Biology (AREA)
- Dispersion Chemistry (AREA)
- Biophysics (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Dermatology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Rheumatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Immunology (AREA)
- Pain & Pain Management (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1206486.1A GB201206486D0 (en) | 2012-04-12 | 2012-04-12 | Vesicular formulations and uses thereof |
| EP13715989.3A EP2836203B1 (en) | 2012-04-12 | 2013-04-12 | Vesicular formulations for use in the treatment of pain or reduced mobility of a joint |
| PCT/EP2013/057742 WO2013153221A1 (en) | 2012-04-12 | 2013-04-12 | Vesicular formulations for use in the treatment of pain or reduced mobility of a joint |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HRP20220700T1 true HRP20220700T1 (hr) | 2022-07-08 |
Family
ID=46208989
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HRP20220700TT HRP20220700T1 (hr) | 2012-04-12 | 2013-04-12 | Vezikularne formulacije za uporabu u liječenju boli ili smanjene pokretljivosti zgloba |
Country Status (26)
| Country | Link |
|---|---|
| US (3) | US20150065461A1 (enExample) |
| EP (1) | EP2836203B1 (enExample) |
| JP (1) | JP2015512926A (enExample) |
| KR (1) | KR102204725B1 (enExample) |
| CN (1) | CN104363894B (enExample) |
| AU (1) | AU2013246822A1 (enExample) |
| BR (1) | BR112014025507B1 (enExample) |
| CA (1) | CA2870111A1 (enExample) |
| CL (1) | CL2014002706A1 (enExample) |
| CO (1) | CO7141430A2 (enExample) |
| DK (1) | DK2836203T3 (enExample) |
| EA (1) | EA039626B1 (enExample) |
| ES (1) | ES2916803T3 (enExample) |
| GB (2) | GB201206486D0 (enExample) |
| HR (1) | HRP20220700T1 (enExample) |
| HU (1) | HUE058972T2 (enExample) |
| IL (1) | IL234862A0 (enExample) |
| IN (1) | IN2014DN08259A (enExample) |
| LT (1) | LT2836203T (enExample) |
| MX (1) | MX2014012198A (enExample) |
| PH (1) | PH12014502079A1 (enExample) |
| PL (1) | PL2836203T3 (enExample) |
| PT (1) | PT2836203T (enExample) |
| SG (1) | SG11201406251VA (enExample) |
| SI (1) | SI2836203T1 (enExample) |
| WO (1) | WO2013153221A1 (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20100255080A1 (en) * | 2009-04-02 | 2010-10-07 | Sesvalia Usa, Llc | Liposomal ALA pharmaceutical and cosmeceutical compositions and methods of treatment |
| MX336482B (es) | 2009-08-21 | 2016-01-21 | Henk-Andre Kroon | Formulaciones vesiculares. |
| GB201205642D0 (en) | 2012-03-29 | 2012-05-16 | Sequessome Technology Holdings Ltd | Vesicular formulations |
| GB201505532D0 (en) * | 2015-03-31 | 2015-05-13 | Sequessome Technology Holdings Ltd | Formulations |
| DK3316857T3 (da) | 2015-06-30 | 2021-10-18 | Sequessome Tech Holdings Limited | Multifasiske sammensætninger |
| HRP20230566T1 (hr) * | 2017-08-22 | 2023-08-18 | Moebius Medical Ltd. | Liposomalna formulacija za podmazivanje zglobova |
| JP2020534285A (ja) | 2017-09-15 | 2020-11-26 | アンパサンド バイオファーマシューティカルズ インコーポレイテッドＡｍｐｅｒｓａｎｄ Ｂｉｏｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｉｎｃ． | 投与および処置の方法 |
| CN110314137B (zh) * | 2018-03-30 | 2022-04-05 | 北京泰德制药股份有限公司 | 一种含有脂质囊泡的冻干制剂 |
| KR20230041954A (ko) | 2021-09-17 | 2023-03-27 | 서울대학교산학협력단 | 골관절염 예방 또는 치료용 약학 조성물 및 건강기능식품 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU4327193A (en) * | 1992-07-08 | 1994-01-31 | Dianorm-Gerate G. Maierhofer | Liposomes, method of preparing them and their use in the preparation of drugs |
| AUPN723395A0 (en) * | 1995-12-19 | 1996-01-18 | Macnaught Medical Pty Limited | Lubrication methods |
| CA2448627A1 (en) * | 2001-05-31 | 2002-12-05 | Pharmacia Corporation | Skin-permeable composition comprising a selective cyclooxygenase-2 inhibitor a monohydric alcohol |
| JP2004535434A (ja) * | 2001-06-25 | 2004-11-25 | デピユイ | 関節炎にかかった関節の処置のためのグリコサミノグリカン類のリポソームカプセル化 |
| US7115666B2 (en) * | 2002-10-15 | 2006-10-03 | Renovis, Inc. | Nitrone compounds, pharmaceutical compositions containing the same and methods for treating inflammation and neuropathic pain |
| CN101541308B (zh) * | 2006-09-28 | 2012-02-01 | 哈达斯特医疗研究服务和开发有限公司 | 甘油磷脂用于关节润滑的用途 |
| AU2010255391C1 (en) * | 2009-06-03 | 2016-10-27 | Sequessome Technology Holdings Limited | Formulations for the treatment of deep tissue pain |
| MX336482B (es) * | 2009-08-21 | 2016-01-21 | Henk-Andre Kroon | Formulaciones vesiculares. |
| EP2340819A1 (en) * | 2009-12-23 | 2011-07-06 | Laboratorios Del. Dr. Esteve, S.A. | Compositions comprising venlafaxine and celecoxib in the treatment of pain |
| US9125786B2 (en) * | 2011-03-31 | 2015-09-08 | Phillip Anthony FEMANO | Method and device to alleviate carpal tunnel syndrome and dysfunctions of other soft tissues |
| CN105229171A (zh) * | 2013-03-13 | 2016-01-06 | 豪夫迈·罗氏有限公司 | 在人pi3kca (pik3ca)基因中检测突变的方法和组合物 |
-
2012
- 2012-04-12 GB GBGB1206486.1A patent/GB201206486D0/en not_active Ceased
-
2013
- 2013-04-12 KR KR1020147031478A patent/KR102204725B1/ko not_active Expired - Fee Related
- 2013-04-12 PT PT137159893T patent/PT2836203T/pt unknown
- 2013-04-12 HR HRP20220700TT patent/HRP20220700T1/hr unknown
- 2013-04-12 GB GB1419074.8A patent/GB2515439B/en not_active Expired - Fee Related
- 2013-04-12 SG SG11201406251VA patent/SG11201406251VA/en unknown
- 2013-04-12 PL PL13715989T patent/PL2836203T3/pl unknown
- 2013-04-12 JP JP2015504977A patent/JP2015512926A/ja active Pending
- 2013-04-12 US US14/391,754 patent/US20150065461A1/en not_active Abandoned
- 2013-04-12 DK DK13715989.3T patent/DK2836203T3/da active
- 2013-04-12 BR BR112014025507-5A patent/BR112014025507B1/pt not_active IP Right Cessation
- 2013-04-12 ES ES13715989T patent/ES2916803T3/es active Active
- 2013-04-12 IN IN8259DEN2014 patent/IN2014DN08259A/en unknown
- 2013-04-12 CA CA2870111A patent/CA2870111A1/en not_active Abandoned
- 2013-04-12 LT LTEPPCT/EP2013/057742T patent/LT2836203T/lt unknown
- 2013-04-12 MX MX2014012198A patent/MX2014012198A/es unknown
- 2013-04-12 AU AU2013246822A patent/AU2013246822A1/en not_active Abandoned
- 2013-04-12 CN CN201380031159.3A patent/CN104363894B/zh not_active Expired - Fee Related
- 2013-04-12 SI SI201331990T patent/SI2836203T1/sl unknown
- 2013-04-12 WO PCT/EP2013/057742 patent/WO2013153221A1/en not_active Ceased
- 2013-04-12 EA EA201491583A patent/EA039626B1/ru unknown
- 2013-04-12 HU HUE13715989A patent/HUE058972T2/hu unknown
- 2013-04-12 EP EP13715989.3A patent/EP2836203B1/en active Active
-
2014
- 2014-09-22 PH PH12014502079A patent/PH12014502079A1/en unknown
- 2014-09-28 IL IL234862A patent/IL234862A0/en unknown
- 2014-10-08 CL CL2014002706A patent/CL2014002706A1/es unknown
- 2014-11-12 CO CO14249925A patent/CO7141430A2/es unknown
-
2016
- 2016-11-11 US US15/349,792 patent/US20170128473A1/en not_active Abandoned
-
2021
- 2021-01-06 US US17/142,624 patent/US20210393655A1/en not_active Abandoned
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP20220700T1 (hr) | Vezikularne formulacije za uporabu u liječenju boli ili smanjene pokretljivosti zgloba | |
| JP2015512926A5 (enExample) | ||
| CL2020000220A1 (es) | Composiciones que comprenden aminoácidos para su uso en el tratamiento de enfermedades relacionadas con la disfunción mitocondrial. | |
| PE20180399A1 (es) | Composiciones transdermicas de ibuprofeno y metodos de uso de las mismas | |
| NZ708453A (en) | Germicidal compositions comprising carboxylic acid mixture and use as topical disinfectants | |
| BRPI1010861A8 (pt) | métodos para tratamento de dor, inflamação ou osteoartrite, pacote e formulação farmacêutica | |
| MX394353B (es) | Formulaciones sinérgicas para control y de repelencia artrópodos picadores. | |
| BR112015005339A8 (pt) | uso de óleo de semente de fruta milagrosa como um ingrediente ativo | |
| BR112015028692A8 (pt) | agente preventivo ou terapêutico para mastite de animal ruminante | |
| MX2016011529A (es) | Formulacion para analogos anticolinergicos suaves. | |
| MY173582A (en) | Extended-release formulation for reducing the frequency of urination and method of use thereof | |
| MX2018005796A (es) | Reduccion de la sensacion de picazon en la piel. | |
| CL2020000221A1 (es) | Composiciones que comprenden aminoácidos para su uso en el tratamiento de enfermedades relacionadas con la disfunción mitocondrial. | |
| MX2015003074A (es) | Formulaciones que comprenden idebenona, n-acetil-s-farnesil-l-cist eína y ergotioneína y usos de las mismas. | |
| WO2014052780A3 (en) | Compositions and methods of use of an inappetance-controlling compound | |
| MX373714B (es) | Composiciones de ketoprofeno de accion prolongada. | |
| DK1893237T3 (da) | Farmaceutisk sammensætning, der omfatter en organopolysiloxan ela-stomer og et solubiliseret aktivt stof | |
| NZ733658A (en) | Compositions and methods for chronic use of a weight-gaining compound | |
| DOP2016000008A (es) | Combinación sinergística de paracetamol/celecoxib para el tratamiento de dolor inflamatorio | |
| AR091705A1 (es) | Uso de cocet sulfato de zinc como agente antibacteriano contra propionibacterium acnes | |
| WO2022115594A8 (en) | Methods of treating deep and superficiel muscle/tendon injuries, and navicular syndrome in quadruped animals. | |
| HRP20201630T1 (hr) | Sastavi i postupci za liječenje kožnog t-staničnog limfoma | |
| MX2014014934A (es) | Metodo para prevenir la dermatitis por alergia a las pulgas en animales de compañía. | |
| Parthiban et al. | Dermatophilosis and its Therapeutic Management in a Ewe. | |
| WO2012095500A3 (en) | Pharmaceutical compositions for the treatment of parasitic diseases, cancer, or skin diseases by topical administration |